Kardiolytics Inc ^Companies

Kardiolytics Inc. is an Artificial Intelligence company specializing in Cardiology. They have developed technology that uses AI to derive crucial diagnostic information about narrowing of the heart blood vessels from inexpensive and widely available imaging of the heart. Their Virtual Cardiac Stress Test (VCAST) is a patented, AI-based medical system that allows for non-invasive, clinical analysis of CT-scan data to assess the hemodynamic significance of coronary artery atherosclerotic stenosis. Kardiolytics Inc. aims to provide effective and safe procedures for coronary vessel analytics, revolutionizing the field of Cardiology by offering a less invasive and more accessible approach to diagnosing heart conditions.